RxDoctor Payments Data

Kevin Trice, MD

Sleep Medicine · Louisville, KYNPI 1467548701

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $132,979 of the $219,519 with a category attached, or 60.6%. 15 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 43.6% of the total. Among sleep medicine clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$219,519in general payments, 2019–2025

Across 282 payments — averaging $778.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Jazz Pharmaceuticals Inc.$96K
  • Avadel CNS Pharmaceuticals, LLC$60K
  • Axsome Therapeutics, Inc.$40K
  • Harmony Biosciences LLC$18K
  • Idorsia Pharmaceuticals US Inc$3K
  • Inspire Medical Systems, Inc.$2K
  • plus $808 from 9 others
$170,502in research payments, 2019–2025

Across 18 payments — averaging $9472.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Livanova USA, Inc.$165K
  • Harmony Biosciences LLC$5K

What the payments were for

  • Consulting fees$47,05321%
  • Speaking & faculty fees$132,97961%
  • Travel & lodging$29,54013%
  • Food & beverage$9,8184%
  • Education$1300%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$219,519 in reported general payments places this provider in the 95th percentile of 28 sleep medicine providers in Kentucky.

See all sleep medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$19,785
Medicare patients
172
Services billed
200

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XywavSodium,calcium,mag,pot Oxybate34$592,965
SunosiSolriamfetol Hcl25$20,520
Modafinil40$6,651
Armodafinil33$2,634
Zolpidem Tartrate36$192
Clonazepam29$95
Trazodone Hcl11$25

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Axsome Therapeutics, Inc.Sunosi$40,111$20,52025 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 28 sleep medicine providers in Kentucky.

Other sleep medicine in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →